| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Fullgoal Fund Management Co., Ltd.
|
12.155m | 0.69% | — | Dec 31 2025 |
| 2 |
China Universal Asset Management Co., Ltd.
|
11.595m | 0.66% | +4.734m | Dec 31 2025 |
| 3 |
Chen (Xiaofa)
|
7.458m | 0.42% | +7.458m | Dec 31 2025 |
| 4 |
ICBC UBS Asset Management Co., Ltd.
|
7.000m | 0.40% | -1.000m | Dec 31 2025 |
| 5 |
Bank of China Investment Management Co., Ltd.
|
5.916m | 0.33% | +592.847k | Dec 31 2025 |
|
1
Fullgoal Fund Management Co., Ltd.
|
0.69%
12.155m
|
|
2
China Universal Asset Management Co., Ltd.
|
0.66%
11.595m
|
|
3
Chen (Xiaofa)
|
0.42%
7.458m
|
|
4
ICBC UBS Asset Management Co., Ltd.
|
0.40%
7.000m
|
|
5
Bank of China Investment Management Co., Ltd.
|
0.33%
5.916m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 2.50% of Innocare Pharma-h, with Fullgoal Fund Management Co., Ltd. the biggest at 0.69%, followed by China Universal Asset Management Co., Ltd. (0.66%) and Chen (Xiaofa) (0.42%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


